Scientists from the University of California, San Francisco, Brian Feldman and Liang Li, may have discovered a key to controlling body fat. They found that manipulating a specific gene could potentially regulate fat. According to the Center for Disease Control and Prevention, 42 percent of U.
S. adults are obese . Weight loss medications such as Ozempic and Wegovy have seen a surge in popularity recently, with a survey revealing that three-quarters of Americans are familiar with these drugs.
Ozempic and Wegovy function by reducing appetite and slowing stomach emptying, leading individuals to feel satiated longer and consequently consume less food, as per UCHealth. The recent study, published in the Journal of Clinical Investigation, explores how medication can aid in the actual burning of fat cells. I'm morbidly obese and suing my insurer because they won't pay for weight loss Patients on weight loss drugs like Ozempic could risk choking to death, study warns The researchers, using human cell cultures and mice, discovered that depriving mice of the transcription factor Klf15 gene allowed white adipose tissue (WAT) to convert into a more efficient thermoregulating form known as brown adipose tissue (BAT).
ScienceAlert explains that there are two distinct types of fat tissue: white fat and brown fat. White fat is stored beneath our skin and around our internal organs, serving as a shock absorber and insulator. White fat is typically what people refer to when discussing fat cells.